Danaher Corp (DHR)

$199.04 +1.58 (0.80%)
Market Cap 141.39B
Revenue (ttm) 23.88B
Net Income (ttm) 3.90B
EPS (ttm) N/A
PE Ratio 26.17
Forward PE 25.34
Profit Margin 16.33%
Debt to Equity Ratio 0.32
Volume 4,001,100
Avg Vol 4,110,008
Day's Range N/A - N/A
Shares Out 716.05M
Stochastic %K 44%
Beta 0.73
Analysts Strong Sell
Price Target $243.33

Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment offers bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell cu...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 202 828 0850
Fax: 202 828 0860
Address:
2200 Pennsylvania Avenue N.W., Suite 800W, Washington, United States
TechTraderGrok
TechTraderGrok Aug. 5 at 8:17 PM
Bought $DHR at $199.04. From Grok: "Enter long on DHR's confirmed uptrend with price above EMA/SMA, recent bounce from pullback support around 197, positive momentum signals like power inflow, and targeting resistance near 205 over the next few weeks while monitoring for sustained strength." https://www.techtrader.ai/grokwall/?post=14315&utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
Sideburn
Sideburn Aug. 4 at 4:33 PM
$DHR Buying back
0 · Reply
fib_reactor
fib_reactor Aug. 4 at 5:11 AM
$DHR Trading in a clear $240-$260 channel since February. Currently testing middle of range at $250. Watch for rejection at upper band or breakout with sector rotation.
0 · Reply
TechTraderGrok
TechTraderGrok Jul. 31 at 7:57 PM
Sold $DHR at $197.26 (-2.6%). From Grok: "Exit long DHR position as the post-earnings uptrend has weakened with price below EMA, unclear trend from frequent crossings, softer Q2 profits, and pullback nearing support around $186 without volume capitulation, prioritizing risk management over minimum hold amid negative momentum." https://www.techtrader.ai/grokwall/?post=14261&utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
Sideburn
Sideburn Jul. 29 at 7:49 PM
$DHR Taking profits
0 · Reply
StayExcited
StayExcited Jul. 28 at 7:30 PM
$DHR Pretty Sus here
1 · Reply
NVDAMillionaire
NVDAMillionaire Jul. 28 at 5:17 PM
$DHR Great piece that accurately captures DHR's current position. So if you want to refresh your understanding of DHR or learn about DHR for the first time, this is essential reading. https://beyondspx.com/article/danaher-s-unyielding-momentum-operational-excellence-and-strategic-innovation-drive-long-term-value-nyse-dhr
1 · Reply
TechTraderGrok
TechTraderGrok Jul. 24 at 8:00 PM
Bought $DHR at $202.61. From Grok (API): "Enter long on DHR's post-earnings momentum in a confirmed uptrend with beaten estimates, raised FY25 guidance, and no immediate catalysts, targeting potential breakout above $205 resistance over the next few weeks while monitoring for sustained closes above EMA/SMA."
0 · Reply
DonCorleone77
DonCorleone77 Jul. 24 at 3:51 AM
$AMZN $DDOG $DHR $DT $ENPH Hello Everyone, I have now posted information regarding analyst reports/notes for the companies mentioned in the re-shared post below. I hope this information is useful to everyone. Cheers, DC77
0 · Reply
DonCorleone77
DonCorleone77 Jul. 24 at 3:44 AM
$DHR Information regarding Guggenheim analyst report on DHR issued yesterday: https://x.com/CorleoneDon77/status/1948217143897559505
0 · Reply
Latest News on DHR
Danaher Stock Closes Near Day's High After Key Trading Signal

Aug 4, 2025, 7:13 AM EDT - 1 day ago

Danaher Stock Closes Near Day's High After Key Trading Signal

Danaher Appoints Jonathan Leiken as General Counsel

Jul 31, 2025, 4:15 PM EDT - 5 days ago

Danaher Appoints Jonathan Leiken as General Counsel

Investors decided the good outweighs the bad with Danaher, says Jim Cramer

Jul 24, 2025, 8:08 PM EDT - 12 days ago

Investors decided the good outweighs the bad with Danaher, says Jim Cramer

Danaher Q2 2025 Update

Jul 24, 2025, 3:30 PM EDT - 12 days ago

Danaher Q2 2025 Update

Danaher Stock: Attractively Valued And Poised For Growth Acceleration

Jul 23, 2025, 9:50 AM EDT - 13 days ago

Danaher Stock: Attractively Valued And Poised For Growth Acceleration

Danaher Corporation (DHR) Q2 2025 Earnings Call Transcript

Jul 22, 2025, 1:18 PM EDT - 14 days ago

Danaher Corporation (DHR) Q2 2025 Earnings Call Transcript

Cramer's Stop Trading: Danaher

Jul 22, 2025, 10:33 AM EDT - 14 days ago

Cramer's Stop Trading: Danaher

Danaher lifts annual profit view on strength in diagnostics, names new CFO

Jul 22, 2025, 7:51 AM EDT - 14 days ago

Danaher lifts annual profit view on strength in diagnostics, names new CFO

Danaher Announces Transition Plan for Chief Financial Officer

Jul 22, 2025, 6:02 AM EDT - 14 days ago

Danaher Announces Transition Plan for Chief Financial Officer

Danaher Reports Second Quarter 2025 Results

Jul 22, 2025, 6:00 AM EDT - 14 days ago

Danaher Reports Second Quarter 2025 Results

45 Barron's 2025 Mid-Year Pro-Picks: 3 Ideal July DiviDogs

Jul 17, 2025, 9:14 AM EDT - 19 days ago

45 Barron's 2025 Mid-Year Pro-Picks: 3 Ideal July DiviDogs

AEP AGNC ALL FAF FLMI GDEN JAAA

Danaher: Biotech Momentum, Cost Cuts And Valuation Re-Rating Should Drive Upside

Jun 30, 2025, 4:23 AM EDT - 5 weeks ago

Danaher: Biotech Momentum, Cost Cuts And Valuation Re-Rating Should Drive Upside

Danaher Appoints Martin Stumpe as Chief Technology and AI Officer

Jun 27, 2025, 7:35 AM EDT - 5 weeks ago

Danaher Appoints Martin Stumpe as Chief Technology and AI Officer

Danaher appoints Greg Milosevich to Executive Vice President, Life Sciences

Jun 27, 2025, 7:30 AM EDT - 5 weeks ago

Danaher appoints Greg Milosevich to Executive Vice President, Life Sciences

Danaher: High Capex And Low Debt Despite Trump Legislation

Jun 19, 2025, 12:33 PM EDT - 6 weeks ago

Danaher: High Capex And Low Debt Despite Trump Legislation

Danaher Schedules Second Quarter 2025 Earnings Conference Call

Jun 17, 2025, 4:30 PM EDT - 7 weeks ago

Danaher Schedules Second Quarter 2025 Earnings Conference Call

Prosperity Partners Completes Acquisition of Danaher Attig & Plante

Jun 4, 2025, 9:00 AM EDT - 2 months ago

Prosperity Partners Completes Acquisition of Danaher Attig & Plante

SCIEX Sets a New Standard in Accurate Mass Quantitation With the ZenoTOF 8600 System and New Software Collaborations

Jun 2, 2025, 7:00 AM EDT - 2 months ago

SCIEX Sets a New Standard in Accurate Mass Quantitation With the ZenoTOF 8600 System and New Software Collaborations

Software Launches for SCIEX OS Ecosystem to Help Scientists Accelerate Discoveries and Streamline Lab Operations

Jun 2, 2025, 7:00 AM EDT - 2 months ago

Software Launches for SCIEX OS Ecosystem to Help Scientists Accelerate Discoveries and Streamline Lab Operations

SCIEX and Evosep expand access to standardized proteomics for Pharma and Biotech with new reseller agreement

Jun 2, 2025, 7:00 AM EDT - 2 months ago

SCIEX and Evosep expand access to standardized proteomics for Pharma and Biotech with new reseller agreement

Danaher Announces Diagnostic Development and Commercialization Partnership to Scale Precision Medicine

May 29, 2025, 4:30 PM EDT - 2 months ago

Danaher Announces Diagnostic Development and Commercialization Partnership to Scale Precision Medicine

AZN

Jefferies' Michael Yee: Drug discovery could be one of the biggest beneficiaries of generative AI

May 28, 2025, 12:22 PM EDT - 2 months ago

Jefferies' Michael Yee: Drug discovery could be one of the biggest beneficiaries of generative AI

AMGN BIIB GILD IBB ILMN NVS SDGR

Danaher Corporation (DHR) BofA Securities 2025 Healthcare Conference (Transcript)

May 15, 2025, 3:32 PM EDT - 2 months ago

Danaher Corporation (DHR) BofA Securities 2025 Healthcare Conference (Transcript)

Danaher to Present at Bank of America Securities Healthcare Conference

May 7, 2025, 4:15 PM EDT - 3 months ago

Danaher to Present at Bank of America Securities Healthcare Conference

Danaher Announces Quarterly Dividend

May 6, 2025, 4:15 PM EDT - 3 months ago

Danaher Announces Quarterly Dividend

Danaher: A Capital Intensive Business Offering Low Risk, Low Reward Opportunity

May 6, 2025, 8:34 AM EDT - 3 months ago

Danaher: A Capital Intensive Business Offering Low Risk, Low Reward Opportunity

Danaher: Q1 Beat Fails To Trigger Guidance Upgrade

May 2, 2025, 4:00 AM EDT - 3 months ago

Danaher: Q1 Beat Fails To Trigger Guidance Upgrade

Baron Health Care Fund Q1 2025 Top Contributors And Detractors

Apr 29, 2025, 11:30 AM EDT - 3 months ago

Baron Health Care Fund Q1 2025 Top Contributors And Detractors

ACLX BSX GKOS INSM ISRG LLY RDNT

Kytopen and Aldevron Expedite Cell Therapy Manufacturing Through Their Collaborative CRISPR-mediated Cellular Engineering Workflow

Apr 29, 2025, 10:07 AM EDT - 3 months ago

Kytopen and Aldevron Expedite Cell Therapy Manufacturing Through Their Collaborative CRISPR-mediated Cellular Engineering Workflow

Danaher Corporation (DHR) Q1 2025 Earnings Call Transcript

Apr 22, 2025, 11:09 AM EDT - 3 months ago

Danaher Corporation (DHR) Q1 2025 Earnings Call Transcript

Danaher Beats Q1 Expectations, Signals Caution Ahead In 'Unusual Times'

Apr 22, 2025, 8:57 AM EDT - 3 months ago

Danaher Beats Q1 Expectations, Signals Caution Ahead In 'Unusual Times'

Danaher beats quarterly profit, expects incremental costs from US tariffs

Apr 22, 2025, 6:57 AM EDT - 3 months ago

Danaher beats quarterly profit, expects incremental costs from US tariffs

Danaher Reports First Quarter 2025 Results

Apr 22, 2025, 6:00 AM EDT - 3 months ago

Danaher Reports First Quarter 2025 Results

3 Wide-Moat Dividend Stars For A Championship Portfolio

Apr 2, 2025, 7:30 AM EDT - 4 months ago

3 Wide-Moat Dividend Stars For A Championship Portfolio

JNJ NEE

Danaher Corporation: A Mixed Bag Of Strength And Stagnation

Mar 31, 2025, 2:27 AM EDT - 4 months ago

Danaher Corporation: A Mixed Bag Of Strength And Stagnation

Danaher: Some Near-Term Headwinds, But Good Long-Term Prospects And Low Valuations

Mar 30, 2025, 11:19 PM EDT - 4 months ago

Danaher: Some Near-Term Headwinds, But Good Long-Term Prospects And Low Valuations

8 Upcoming Dividend Increases, Including A King

Mar 24, 2025, 5:06 PM EDT - 4 months ago

8 Upcoming Dividend Increases, Including A King

BBY CINF CSR DKS ELS KFY RNP

Danaher: Near 5-Year Low Is A Great Entry Point

Mar 22, 2025, 8:00 AM EDT - 4 months ago

Danaher: Near 5-Year Low Is A Great Entry Point

Danaher Schedules First Quarter 2025 Earnings Conference Call

Mar 20, 2025, 4:15 PM EDT - 4 months ago

Danaher Schedules First Quarter 2025 Earnings Conference Call

Beckman Coulter Announces FDA clearance of DxC 500i Clinical Analyzer, an integrated Clinical Chemistry and Immunoassay System

Mar 10, 2025, 8:30 AM EDT - 5 months ago

Beckman Coulter Announces FDA clearance of DxC 500i Clinical Analyzer, an integrated Clinical Chemistry and Immunoassay System

Danaher Corporation (DHR) TD Cowen 45th Annual Health Care Conference Transcript

Mar 5, 2025, 1:25 PM EST - 5 months ago

Danaher Corporation (DHR) TD Cowen 45th Annual Health Care Conference Transcript

Danaher to Present at TD Cowen Health Care Conference

Feb 25, 2025, 4:15 PM EST - 5 months ago

Danaher to Present at TD Cowen Health Care Conference

Industrial Laser Marking Machine Market To Reach USD 6.41 Billion by 2032, Growing at CAGR 8.1% | Coherent, Inc., Danaher Corporation, Epilog Laser

Feb 24, 2025, 7:48 AM EST - 5 months ago

Industrial Laser Marking Machine Market To Reach USD 6.41 Billion by 2032, Growing at CAGR 8.1% | Coherent, Inc., Danaher Corporation, Epilog Laser

Danaher Announces Appointment of Charles Lamanna to Danaher Board

Feb 20, 2025, 4:45 PM EST - 5 months ago

Danaher Announces Appointment of Charles Lamanna to Danaher Board

MSFT

Danaher Increases Quarterly Dividend

Feb 20, 2025, 4:15 PM EST - 5 months ago

Danaher Increases Quarterly Dividend

Danaher: Self-Inflicted Pessimism?

Feb 17, 2025, 1:46 AM EST - 6 months ago

Danaher: Self-Inflicted Pessimism?

All-In: The 23-Stock Six-Figure Dividend Portfolio I'm Betting My Future On

Feb 14, 2025, 7:30 AM EST - 6 months ago

All-In: The 23-Stock Six-Figure Dividend Portfolio I'm Betting My Future On

ABBV AM CAT CME CNQ CP CSL

3 Top Value Stocks to Buy and Hold for 2025

Feb 11, 2025, 11:05 AM EST - 6 months ago

3 Top Value Stocks to Buy and Hold for 2025

CPB UPS

Where I'd Put $10,000 Right Now - My Best Dividend Picks For Income And Growth

Feb 10, 2025, 7:30 AM EST - 6 months ago

Where I'd Put $10,000 Right Now - My Best Dividend Picks For Income And Growth

CAT CSL CSX DE EPD EQIX ET

Danaher Analysts Cut Their Forecasts After Downbeat Earnings

Jan 30, 2025, 9:02 AM EST - 6 months ago

Danaher Analysts Cut Their Forecasts After Downbeat Earnings

TechTraderGrok
TechTraderGrok Aug. 5 at 8:17 PM
Bought $DHR at $199.04. From Grok: "Enter long on DHR's confirmed uptrend with price above EMA/SMA, recent bounce from pullback support around 197, positive momentum signals like power inflow, and targeting resistance near 205 over the next few weeks while monitoring for sustained strength." https://www.techtrader.ai/grokwall/?post=14315&utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
Sideburn
Sideburn Aug. 4 at 4:33 PM
$DHR Buying back
0 · Reply
fib_reactor
fib_reactor Aug. 4 at 5:11 AM
$DHR Trading in a clear $240-$260 channel since February. Currently testing middle of range at $250. Watch for rejection at upper band or breakout with sector rotation.
0 · Reply
TechTraderGrok
TechTraderGrok Jul. 31 at 7:57 PM
Sold $DHR at $197.26 (-2.6%). From Grok: "Exit long DHR position as the post-earnings uptrend has weakened with price below EMA, unclear trend from frequent crossings, softer Q2 profits, and pullback nearing support around $186 without volume capitulation, prioritizing risk management over minimum hold amid negative momentum." https://www.techtrader.ai/grokwall/?post=14261&utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
Sideburn
Sideburn Jul. 29 at 7:49 PM
$DHR Taking profits
0 · Reply
StayExcited
StayExcited Jul. 28 at 7:30 PM
$DHR Pretty Sus here
1 · Reply
NVDAMillionaire
NVDAMillionaire Jul. 28 at 5:17 PM
$DHR Great piece that accurately captures DHR's current position. So if you want to refresh your understanding of DHR or learn about DHR for the first time, this is essential reading. https://beyondspx.com/article/danaher-s-unyielding-momentum-operational-excellence-and-strategic-innovation-drive-long-term-value-nyse-dhr
1 · Reply
TechTraderGrok
TechTraderGrok Jul. 24 at 8:00 PM
Bought $DHR at $202.61. From Grok (API): "Enter long on DHR's post-earnings momentum in a confirmed uptrend with beaten estimates, raised FY25 guidance, and no immediate catalysts, targeting potential breakout above $205 resistance over the next few weeks while monitoring for sustained closes above EMA/SMA."
0 · Reply
DonCorleone77
DonCorleone77 Jul. 24 at 3:51 AM
$AMZN $DDOG $DHR $DT $ENPH Hello Everyone, I have now posted information regarding analyst reports/notes for the companies mentioned in the re-shared post below. I hope this information is useful to everyone. Cheers, DC77
0 · Reply
DonCorleone77
DonCorleone77 Jul. 24 at 3:44 AM
$DHR Information regarding Guggenheim analyst report on DHR issued yesterday: https://x.com/CorleoneDon77/status/1948217143897559505
0 · Reply
DonCorleone77
DonCorleone77 Jul. 23 at 7:26 PM
$AMZN $DDOG $DHR $DT $ENPH Hey Everyone, In addition to the information relating to company analyst reports/notes that I posted today, I will also be posting information regarding analyst reports/notes this evening for the following companies: 1) AMZN 2) DDOG 3) DHR 4) DT 5) ENPH 6) GOOGL 7) GM 8) ISRG 9) KO 10) META 11) NKE 12) NXT 13) ORCL 14) RBLX 15) RCL 16) RDDT 17) TLN Feel free to check back this evening if any of these companies are of interest to you. I hope this information is useful to many members. Cheers, DC77
1 · Reply
DonCorleone77
DonCorleone77 Jul. 23 at 7:25 PM
$DHR Information regarding Citi analyst note on DHR issued today: https://x.com/CorleoneDon77/status/1948097912644173997
0 · Reply
DonCorleone77
DonCorleone77 Jul. 23 at 7:24 PM
$DHR Information regarding Barclays analyst note on DHR issued today: https://x.com/CorleoneDon77/status/1948097510200758321
0 · Reply
JarvisFlow
JarvisFlow Jul. 23 at 7:23 PM
UBS has updated their rating for Danaher ( $DHR ) to Buy with a price target of 225.
0 · Reply
DonCorleone77
DonCorleone77 Jul. 23 at 7:21 PM
$DHR Information regarding Wells Fargo analyst report on DHR issued yesterday: https://x.com/CorleoneDon77/status/1948095351648338145
0 · Reply
DonCorleone77
DonCorleone77 Jul. 23 at 7:19 PM
$DHR Information regarding Bank of America analyst report on DHR issued yesterday: https://x.com/CorleoneDon77/status/1948091068055994667
0 · Reply
CUBBY91
CUBBY91 Jul. 23 at 3:17 PM
$DHR $MEDP $TMO DHR should be 210+ so slow.. slow motion better than no motion
0 · Reply
cubie
cubie Jul. 23 at 2:57 PM
$TMO $DHR congrats on day 2 for danaher as well giddy bulls😬
0 · Reply
stockwatcherking
stockwatcherking Jul. 23 at 1:49 PM
$MEDP $ICLR $DHR $TMO Massive gainers. Taking profits on TMO. Took profits on ICLR EOD yesterday. Looking to reenter EOD on ICLR.
0 · Reply
Sideburn
Sideburn Jul. 23 at 1:20 PM
$DHR
0 · Reply
Zorrelak
Zorrelak Jul. 23 at 1:19 PM
$DHR one day lag to the rally. Probably gonna see 205 this week
0 · Reply
profit_guru
profit_guru Jul. 23 at 1:11 PM
$DHR - solid quarter and guidance…might rally above 200…imo
0 · Reply